Drug Profile
Anticancer monoclonal antibody A33 - Ludwig Institute for Cancer Research
Alternative Names: 124I-huA33; 131I-huA33; 131I-huAb A33; huA33 antibodyLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Ludwig Institute for Cancer Research
- Class Antineoplastics; Monoclonal antibodies; Radiopharmaceuticals
- Mechanism of Action Differentiation antigen inhibitors; Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Colorectal cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Colorectal-cancer in Australia (IV, Infusion)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Colorectal-cancer in USA (IV, Infusion)